Kiniksa Pharmaceuticals (KNSA) Competitor Comparison
We are evaluating the key criteria listed to compare Kiniksa Pharmaceuticals (KNSA) against its competitors in the Biotechnology industry.
Market Capitalization
100 / 368Gross Profits
36 / 278Total Revenue
46 / 300EBITDA
72 / 337Free Cashflow
38 / 352Quick Ratio
230 / 357Earnings per Share
49 / 359Dividend yield
0 / 6Total Cash
156 / 358Performance 3 years
56 / 368Performance 5 years
59 / 368Performance 10 years
97 / 368Linearity 3 years
164 / 368Linearity 5 years
207 / 368Linearity 10 years
45 / 368Total Rank
176 / 368Dividend Rank
182 / 368Valuation Rank
64 / 368Piotroski Rank
10 / 368Muliplier Rank
135 / 368Market Capitalization - KNSA ranking 100 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.